Propranolol Dosing Guidelines

Standard Adult Dosing by Indication

The American College of Cardiology recommends starting with propranolol immediate-release 80 mg daily in 2 divided doses, or propranolol extended-release 80 mg once daily, for adults with cardiovascular indications, such as hypertension, angina, and anxiety 1
For anxiety and physical symptoms, the recommended starting dose is 30-60 mg daily in divided doses or as a single dose with long-acting formulations, with lower doses of 10-40 mg three or four times daily sufficient for situational anxiety while minimizing side effects 1, 2

The British Journal of Dermatology recommends a standard starting dose of 1 mg/kg/day divided into 2-3 doses, administered with food, for infantile hemangiomas, with a maximum dose of 0.5 mg/kg/day in 3 divided doses for suspected PHACES syndrome 3, 4
The target maintenance dose is 2-3 mg/kg/day divided into multiple daily doses, with a maximum dose of 3 mg/kg/day if inadequate response 3, 4

Elderly patients should start at lower doses and titrate more gradually due to increased sensitivity to beta-blockers, with consideration of 40 mg twice daily or 80 mg extended-release as the initial dose 1, 2

Before initiating propranolol, screen for absolute contraindications, including second or third-degree heart block, decompensated heart failure, asthma, cardiogenic shock, sinus node dysfunction, and severe bradycardia or hypotension 1
Baseline cardiovascular assessment should include heart rate and blood pressure measurement, cardiovascular examination, and ECG and echocardiogram only in patients with suspected cardiac abnormalities or segmental head/neck hemangiomas 1, 3

Administer propranolol with food to reduce hypoglycemia risk, particularly important in pediatric patients, and hold doses during diminished oral intake or vomiting 3, 4
Never abruptly discontinue propranolol after chronic use; taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 1, 2
Monitor for hypotension and bradycardia, especially during dose escalation, and watch for signs of excessive beta-blockade, such as dizziness, extreme fatigue, and syncope 1, 2

The American Academy of Pediatrics recommends starting propranolol at 1 mg/kg/day divided into 2-3 doses with food for infantile hemangiomas, with a target maintenance dose of 2-3 mg/kg/day divided into multiple daily doses 5
The American Heart Association suggests that propranolol can be initiated 5-21 days post-myocardial infarction, with a maintenance dose of 180-240 mg daily based on serum drug levels 6

For pediatric patients, especially those with suspected PHACE syndrome, propranolol should be administered 3 times daily to minimize abrupt blood pressure changes, with a starting dose of 0.5 mg/kg/day 5
The American Academy of Pediatrics advises that propranolol should always be administered with or after feeding to prevent hypoglycemia, and doses should be held during diminished oral intake or vomiting 5
For infantile hemangiomas, propranolol treatment should be continued until at least 12 months of age, ideally 12-15 months to minimize rebound growth 5

The American College of Cardiology recommends that propranolol be initiated 5-21 days post-myocardial infarction, with a maintenance dose of 180-240 mg daily based on serum drug levels, resulting in a 26% reduction in all-cause mortality 6

The American College of Physicians recommends a therapeutic range for propranolol in essential tremor of 80 to 240 mg daily, based on consistent evidence from multiple controlled trials 7, 8
The established therapeutic range for propranolol in essential tremor is 80 to 240 mg daily, with a maximum dose of up to 240 mg daily if needed for adequate tremor control 7, 8

Common side effects of propranolol include fatigue, depression, nausea, dizziness, and insomnia, though these are generally well-tolerated 7, 8
An ECG is only required if indicated, such as in cases of cardiac symptoms, abnormal heart rate, or family history of sudden death 9

The British Journal of Dermatology recommends performing baseline cardiovascular assessment including heart rate and blood pressure measurement, and cardiovascular examination with auscultation in adolescents before initiating propranolol 10
The British Journal of Dermatology suggests that an ECG is only required if the patient has abnormal heart rate for age, strong family history of sudden death or arrhythmia, episodes of loss of consciousness, or maternal history of connective tissue disease 10